Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
Natco Pharma gets nod for generic Everolimus tablets
The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...
Granules shares gain over 5% on U.S. FDA nod for ADHD generic capsules
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
Le Lézard1d
A.forall Announces First US Launch with Coveted Competitive Generic Therapy (CGT) Exclusivity of Tromethamine Injection 18GM/500mL
A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...
Granules India gets USFDA’s nod for ADHD generic
Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
Daily1d
Natco Pharma gets approval for Everolimus tablets for Oral Suspension for subependymal giant cell astrocytoma
Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...
U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.
Daily1d
Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate
Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...
Hosted on MSN6d
FDA approves drug application for Lupin’s heart failure therapy
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Pharmabiz1d
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...
money.rediff1d
Granules India Gets USFDA Nod for ADHD Treatment
Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...
Pharmabiz3d
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...